Search The Medical Knowledge Base

Drug Details

SCHERIPROCT Suppositories

• Drug Class Description
  Anti-inflammatory
• Generic Name
  Prednisolone hexanoate
• Presentation
  Suppository
• Description
  Each yellowish-white suppository contains: Prednisolone hexanoate 1.3 mg Cinchocaine hydrochloride 1.0 mg
• Indications
  For the symptomatic relief of haemorrhoids and pruritus ani in the short term (5-7 days).
• Adult Dosage
  

  One Scheriproct suppository to be inserted daily. In severe cases one suppository two to three times daily at the beginning of treatment. The suppositories should be inserted after defaecation.

• Contra Indications
  

  Viral infections. Primary bacterial or fungal infections. Secondary infections of the skin in the absence of appropriate anti-infective therapy. Known sensitivity to local anaesthetics.

• Special Precautions
  

  Warnings: In infants, long-term continuous therapy with topical corticosteroids should be avoided. Occlusion is not appropriate on the perineum. Adrenal suppression can occur, even without occlusion.

  As with all topical steroids, there is a risk of developing skin atrophy following extensive therapy. The application of unusually large quantities of topical corticoids may result in the absorption of systemically active amounts of corticoid. Secondarily infected dermatoses definitely require additional therapy with antibiotics or chemotherapeutic agents. This treatment can often be topical, but for heavy infections systemic antibacterial therapy may be necessary. If fungal infections are present, a topically active antimycotic should be applied.

• Interactions
  

  None known. Pregnancy and lactation There is inadequate evidence of safety in human pregnancy. Topical administration of corticosteroids to pregnant animals can cause abnormalities of foetal development, including cleft palate and intra-uterine growth retardation. There may therefore be a very small risk of such effects on the human foetus.

• Adverse Drug Reactions
  As with all topical steroids, there is a risk of developing skin atrophy following extensive therapy. Allergic skin reactions may occur.